REGN vs TECH
Regeneron Pharmaceuticals Inc (REGN) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the REGN and TECH stock pages for the full models.
Not investment advice.